Quantification of human T-cell lymphotropic virus type 1 proviral load by quantitative competitive polymerase chain reaction

Journal of Virological Methods

Volumn 75, Issue 2, 1998, Pages 123-140

  Albrecht, Björn ^a,b   Collins, Nathaniel D ^b   Newbound, Garret C ^b   Ratner, Lee ^d   Lairmore, Michael D ^a,b,c  

^a Molecular   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d Pathol Molec Microbiol W   (United States)

Author keywords

Animal model; Diagnosis; HTLV 1; Pathogenesis; Quantitative competitive polymerase chain reaction; Retrovirus

Indexed keywords

VIRUS DNA;

CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; MONONUCLEAR CELL; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVIRUS; RABBIT; RETROVIRUS; REVIEW; VIRUS DETECTION; VIRUS INFECTION; VIRUS LOAD;

EID: 0031727523     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(98)00087-1     Document Type: Article

References (66)

1. Abbott M.A., Poiesz B.J., Byrne B.C., Kwok S., Sninsky J.J., Ehrlich G.D. Enzymatic gene amplification: qualitative and quantitative methods for detecting proviral DNA amplified in vitro. J. Infect. Dis. 158(6):1988;1158-1169.
2. Bagnarelli P., Menzo S., Valenza A. et al. Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS. J. Virol. 66(12):1992;7328-7335.
3. Bazarbachi A., Huang M., Gessain A. et al. Human T-cell-leukemia virus type I in post-transfusional spastic paraparesis: complete proviral sequence from uncultured blood cells. Int. J. Cancer. 63(4):1995;494-499.
4. Cimarelli A., Duclos C.A., Gessain A. et al. Quantification of HTLV-II proviral copies by competitive polymerase chain reaction in peripheral blood mononuclear cells of Italian injecting drug users, central Africans, and Amerindians. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 10(2):1995;198-204.
5. Cimarelli A., Zambruno G., Marconi A., Girolomoni G., Bertazzoni U., Giannetti A. Quantitation by competitive PCR of HIV-1 proviral DNA in epidermal Langerhans cells of HIV-infected patients. J. Acquired Immune Defic. Syndr. 7(3):1994;230-235.
6. Clementi M., Bagnarelli P., Manzin A., Menzo S. Competitive polymerase chain reaction and analysis of viral activity at the molecular level. Genet. Anal. Tech. Appl. 11(1):1994;1-6.
7. Clementi M., Menzo S., Manzin A., Bagnarelli P. Quantitative molecular methods in virology. Arch. Virol. 140(9):1995;1523-1539.
8. Cockerell G.L., Lairmore M., De B., Rovnak J., Hartley T.M., Miyoshi I. Persistent infection of rabbits with HTLV-I: patterns of anti-viral antibody reactivity and detection of virus by gene amplification. Int. J. Cancer. 45(1):1990;127-130.
9. Collins N.D., Newbound G.C., Ratner L., Lairmore M.D. In vitro CD4+ lymphocyte transformation and infection in a rabbit model with a molecular clone of human T-cell lymphotrophic virus type 1. J. Virol. 70(10):1996;7241-7246.
10. I reduces viral infectivity in vivo. Blood 91 (12), 4701-4707.
11. Derse D., Mikovits J., Ruscetti F. X-I and X-II open reading frames of HTLV-1 are not required for virus replication or for immortalization of primary T-cells in vitro. Virology. 237:1997;123-128.
12. Desforges B., Hatin I., Akarid K., Sinet M. Competitive reverse transcription-polymerase chain reaction for quantifying murine AIDS virus. J. Virol. Methods. 62(2):1996;161-168.
13. Ehrlich G.D., Greenberg S., Abbot M.A. Detection of human T-cell lymphoma/leukemia viruses. Innis M.A., Gelfand D.H., Sninsky J.J., White T.J. PCR Protocols - A Guide to Methods and Applications. 1990;325-336 Academic Press, San Diego, CA.
14. Evangelista A., Maroushek S., Minnigan H. et al. Nucleotide sequence analysis of a provirus derived from an individual with tropical spastic paraparesis. Microb. Pathog. 8(4):1990;259-278.
15. Feuer G., Fraser J.K., Zack J.A., Lee F., Feuer R., Chen I.S. Human T-cell leukemia virus infection of human hematopoietic progenitor cells: maintenance of virus infection during differentiation in vitro and in vivo. J. Virol. 70(6):1996;4038-4044.
16. Franchini G. Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood. 86(10):1995;3619-3639.
17. Gadzar, A.F., Carney, D.N., Bunn, P.A., Russell, E.K., Jaffe, E.S., Schechter, G.P., Guccion, 1980. Mitogen requirements for in viro propagation of cutaneous T-cell lymphomas. Blood 55(3), 409-417.
18. Gessain A., Barin F., Vernant J.C., Gout O., Maurs L., Calender A., de The G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 2(8452):1985;407-410.
19. Gessain A., Boeri E., Yanagihara R., Gallo R.C., Franchini G. Complete nucleotide sequence of a highly divergent human T-cell leukemia (lymphotropic) virus type I (HTLV-I) variant from melanesia: genetic and phylogenetic relationship to HTLV-I strains from other geographical regions. J. Virol. 67(2):1993;1015-1023.
20. Gill P.S., Harrington W. Jr., Kaplan M.H. et al. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. New Engl. J. Med. 332(26):1995;1744-1748.
21. Gilliland G., Perrin S., Blanchard K., Bunn H.F. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc. Natl. Acad. Sci. USA. 87(7):1990;2725-2729.
22. Gray G.S., Bartman T., White M. Nucleotide sequence of the core (gag) gene from HTLV-1 isolate MT-2. Nucleic Acids Res. 17(19):1989;7998.
23. Ibrahim F., de The G., Gessain A. Isolation and characterization of a new simian T-cell leukemia virus type 1 from naturally infected celebes macaques (Macaca tonkeana): complete nucleotide sequence and phylogenetic relationship with the Australo-Melanesian human T-cell leukemia virus type 1. J. Virol. 69(11):1995;6980-6993.
24. Izumo S., Goto I., Itoyama Y. et al. Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial. Neurology. 46(4):1996;1016-1021.
25. Kaumaya, P.T., Conrad, S.F., DiGeorge, A.M., Lairmore, M.D., 1995. Glycosylation-dependent peptide antigenic determinants of env gp46 HTLV-1. Leukemia 9(Suppl 1), S133-138.
26. Kazanji M., Moreau J.P., Mahieux R., Bonnemains B., Bomford R., Gessain A., de The G. HTLV-I infection in squirrel monkeys (Saimiri sciureus) using autologous, homologous, or heterologous HTLV-I-transformed cell lines. Virology. 231(2):1997;258-266.
27. Kimata J.T., Wong F.H., Wang J.J., Ratner L. Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones. Virology. 204(2):1994;656-664.
28. Kira J., Koyanagi Y., Yamada T. et al. Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study. Ann. Neurol. 29(2):1991;194-201.
29. Koralnik I.J., Boeri E., Saxinger W.C. et al. Phylogenetic associations of human and simian T-cell leukemia/lymphotropic virus type I strains: evidence for interspecies transmission. J. Virol. 68(4):1994;2693-2707.
30. Korber B., Okayama A., Donnelly R., Tachibana N., Essex M. Polymerase chain reaction analysis of defective human T-cell leukemia virus type I proviral genomes in leukemic cells of patients with adult T-cell leukemia. J. Virol. 65(10):1991;5471-5476.
31. Kubota R., Fujiyoshi T., Izumo S., Yashiki S., Maruyama I., Osame M., Sonoda S. Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathy. J. Neuroimmunol. 42(2):1993;147-154.
32. Lairmore M.D., Lal R.B. Other human retrovirus infections: HTLV-I and HTLV-II. Schochetman G., George J.R. AIDS Testing Methodology and Management Issues. 1992;168-188 New York, Springer Verlag.
33. Lairmore M.D., Roberts B., Frank D., Rovnak J., Weiser M.G., Cockerell G.L. Comparative biological responses of rabbits infected with human T-lymphotropic virus type I isolates from patients with lymphoproliferative and neurodegenerative disease. Int. J. Cancer. 50(1):1992;124-130.
34. Lairmore M.D., DiGeorge A.M., Conrad S.F., Trevino A.V., Lal R.B., Kaumaya P.T. Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction. J. Virol. 69(10):1995;6077-6089.
35. Lazo, A., Bailer, R.T., Lairmore, M.D., Yee, J.A., Andrews, J., Stevens, V.C., Blakeslee, J.R., 1994. Sexual transmission of simian T-lymphotropic virus type I: a model of human T-lymphotropic virus type I infection. Leukemia 8(Suppl 1), S222-226.
36. Lee C.C., Caskey T.C. cDNA cloning using degenerate drimers. Innis M.A., Gelfand D.H., Sninsky J.J., White T.J. PCR Protocols - A Guide to Methods and Applications. 1990;46-53 Academic Press, San Diego, CA.
37. Malik K.T., Even J., Karpas A. Molecular cloning and complete nucleotide sequence of an adult T cell leukaemia virus/human T cell leukaemia virus type I (ATLV/HTLV-I) isolate of Caribbean origin: relationship to other members of the ATLV/HTLV-I subgroup. J. Gen. Virol. 69(7):1988;1695-1710.
38. Maniatis T., Fritsch E.F., Sambrook J. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor University Press, Cold Spring Harbor, NY.
39. Miyoshi I., Kubonishi I., Yoshimoto S. et al. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature. 294:1981;770-771.
40. Mukhopadhyaya R., Sadaie M.R. Nucleotide sequence analysis of HTLV-I isolated from cerebrospinal fluid of a patient with TSP/HAM: comparison to other HTLV-I isolates. AIDS Res. Hum. Retrovir. 9(2):1993;109-114.
41. Ono A., Mochizuki M., Yamaguchi K., Miyata N., Watanabe T. Increased number of circulating HTLV-1 infected cells in peripheral blood mononuclear cells of HTLV-1 uveitis patients: a quantitative polymerase chain reaction study. Br. J. Ophthalmol. 79(3):1995;270-276.
42. Osame M., Usuku K., Izumo S. et al. HTLV-I associated myelopathy, a new clinical entity [letter]. Lancet. 1(8488):1986;1031-1032.
43. Ohshima K., Kikuchi M., Masuda Y. et al. Defective provirus form of human T-cell leukemia virus type I in adult T-cell leukemia/lymphoma: clinicopathological features. Cancer Res. 51(17):1991;4639-4642.
44. Pardi D., Switzer W.M., Hadlock K.G., Kaplan J.E., Lal R.B., Folks T.M. Complete nucleotide sequence of an Amerindian human T-cell lymphotropic virus type II (HTLV-II) isolate: identification of a variant HTLV-II subtype b from a Guaymi Indian. J. Virol. 67(8):1993;4659-4664.
45. Piatak M. Jr., Luk K.C., Williams B., Lifson J.D. Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. Biotechniques. 14(1):1993;70-81.
46. Piatak M. Jr., Saag M.S., Yang L.C. et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science. 259(5102):1993;1749-1754.
47. Picard V., Ersdal-Badju E., Lu A., Bock S.C. A rapid and efficient one-tube PCR-based mutagenesis technique using Pfu DNA polymerase. Nucleic Acids Res. 22(13):1994;2587-2591.
48. Poiesz B.J., Ruscetti F.W., Gazdar A.F., Bunn P.A., Minna J.D., Gallo R.C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA. 77(12):1980;7415-7419.
49. Quesenberry, K.E., 1994. Rabbits. In: Birchard, S.J., Sherding, R.G. (Eds.), Saunders Manual of Small Animal Practice. Philadelphia, WB Saunders, pp. 1346.
50. Ratner L., Josephs S.F., Starcich B., Hahn B., Shaw G.M., Gallo R.C., Wong-Staal F. Nucleotide sequence analysis of a variant human T-cell leukemia virus (HTLV-Ib) provirus with a deletion in pX-I. J. Virol. 54(3):1985;781-790.
51. Ratner L., Philpott T., Trowbridge D.B. Nucleotide sequence analysis of isolates of human T-lymphotropic virus type 1 of diverse geographical origins. AIDS Res. Hum. Retrovir. 7(11):1991;923-941.
52. Renjifo B., Chou K., Soto Ramirez L., Garcia Vallejo F., Essex M. Human T cell leukemia virus type I (HTLV-I) molecular genotypes and disease outcome. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 13(Suppl 1):1996;146-153.
53. Richardson J.H., Edwards A.J., Cruickshank J.K., Rudge P., Dalgleish A.G. In vivo cellular tropism of human T-cell leukemia virus type I. J. Virol. 64(11):1990;5682-5687.
54. Saito M., Furukawa Y., Kubota R. et al. Frequent mutation in pX region of HTLV-1 is observed in HAM/TSP patients, but is not specifically associated with the central nervous system lesions. J. Neurovirol. 1(3-4):1995;286-294.
55. Saito M., Furukawa Y., Kubota R., Usuku K., Izumo S., Osame M., Yoshida M. Mutation rates in LTR of HTLV-1 in HAM/TSP patients and the carriers are similarly high to Tax/Rex-coding sequence. J. Neurovirol. 2(5):1996;330-335.
56. Sakurai H., Kondo N., Ishiguro N., Mikuni C., Ikeda H., Wakisaka A., Yoshiki T. Molecular analysis of a HTLV-IpX defective human adult T-cell leukemia. Leuk. Res. 16(9):1992;941-946.
57. Salemi M., Vandamme A.M., Guano F., Gradozzi C., Cattaneo E., Casoli C., Bertazzoni U. Complete nucleotide sequence of the Italian human T-cell lymphotropic virus type II isolate Gu and phylogenetic identification of a possible origin of South European epidemics. J. Gen. Virol. 77(6):1996;1193-1201.
58. Saxon A., Stevens R.H., Quan S.G., Golde D.W. Immunologic characterization of hairy cell leukemias in continuous culture. J. Immunol. 120(3):1978;777-782.
59. Seiki M., Hattori S., Hirayama Y., Yoshida M. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc. Natl. Acad. Sci. USA. 80(12):1983;3618-3622.
60. Sheremata W.A., Benedict D., Squilacote D.C., Sazant A., DeFreitas E. High-dose zidovudine induction in HTLV-I-associated myelopathy: safety and possible efficacy. Neurology. 43(10):1993;2125-2129.
61. Shimotohno K., Takahashi Y., Shimizu N. et al. Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene. Proc. Natl. Acad. Sci. USA. 82(10):1985;3101-3105.
62. Tang J., Lagace G., Collu R. Simple method for constructing internal standards for competitive PCR. Biotechniques. 21(3):1996;378-380.
63. Vahlenkamp T.W., De Ronde A., Horzinek M.C., Egberink H.F. Quantification of feline immunodeficiency virus (FIV) RNA in the plasma of infected cats. Berl. Munch. Tierarztl. Wochenschr. 109(8):1996;265-269.
64. Van Brussel M., Goubau P., Rousseau R., Desmyter J., Vandamme A.M. Complete nucleotide sequence of the new simian T-lymphotropic virus, STLV-PH969 from a Hamadryas baboon, and unusual features of its long terminal repeat. J. Virol. 71(7):1997;5464-5472.
65. Wattel E., Mariotti M., Agis F. et al. Quantification of HTLV-1 proviral copy number in peripheral blood of symptomless carriers from the French West Indies. J. Acquired Immune Defic. Syndr. 5(9):1992;943-946.
66. Watson A., Ranchalis J., Travis B. et al. Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival. J. Virol. 71(1):1997;284-290.